Get startedLog in
    Picture of Interpace Biosciences logo

    IDXG — Interpace Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Interpace Diagnostics Says New York State Approves Commercialization Of Thyramir Now In Three Specimens

    Picture of Interpace Biosciences logoInterpace Biosciences
    23/04/2019 12:11
    April 23 (Reuters) - Interpace Diagnostics Group Inc
 IDXG.O :
    * INTERPACE DIAGNOSTICS GROUP INC - STATE OF NEW YORK
APPROVES
COMMERCIALIZATION OF THYRAMIR NOW IN THREE SPECIMENS

Source text for Eikon:  ID:nGNX3W55jR 
Further company coverage:  IDXG.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Interpace Biosciences

    See all news